|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/28 | |||
| A61P 35/00 |
| (11) | Number of the document | 1765397 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05754219.3 |
| Date of filing the European patent application | 2005-05-25 | |
| (97) | Date of publication of the European application | 2007-03-28 |
| (45) | Date of publication and mention of the grant of the patent | 2012-10-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/018322 |
| Date | 2005-05-25 |
| (87) | Number | WO 2005/116077 |
| Date | 2005-12-08 |
| (30) | Number | Date | Country code |
| 573896 P | 2004-05-25 | US |
| (72) |
PARRY, Graham, C., US
MAZAR, Andrew P., US
|
| (73) |
Tactic Pharma, LLC,
1007 Church Street, Suite 307, Evanston 60201,
US
|
| (54) | Inhibitory antibodies binding the complex of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) |
| Inhibitory antibodies binding the complex of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) |